Stock Day Media

Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day Podcast

Listen Later
The Stock Day Podcast welcomed Acasti Pharma, Inc. (Nasdaq:ACST), a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. CEO of the Company, Jan D’Alvise, joined Stock Day host Everett Jolly. 


Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy
...more
View all episodesView all episodes
Download on the App Store
Stock Day MediaBy Stock Day Media
  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

31 ratings

More shows like Stock Day Media

View all
Bad Friends by Bobby Lee & Andrew Santino

Bad Friends

14,120 Listeners